Rapid innovation, expanding clinical pipelines, and rising demand for curative treatments position gene therapy as a ...

It can be fairly said that therapy as we know it today is a modern and Western concept. We tend to think of treatment ...

Hyperbaric Oxygen Therapy (HBOT) is emerging as a science-backed tool to boost brain performance, reverse decline, and ...

Founded by Dr. Betty Murray and powered forward with the operational and strategic leadership of Resendez, Menrva is stepping ...

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific ...

Detailed price information for Biocryst Pharma Inc (BCRX-Q) from The Globe and Mail including charting and trades.

Sutter Health is the first hospital in the Sacramento Region to offer accelerated TMS therapy for treatment-resistant ...

Mycosis fungoides, the most prevalent CTCL subtype, accounts for the majority of cases. Although early-stage disease has a five-year survival rate of roughly 88%, it is a chronic cancer with ...

Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple ...

Incyte INCY announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain-the Swoop® system-today announced ...